Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
grade F 1.21 0.83% 0.01
OPGN closed up 0.83 percent on Monday, March 18, 2019, on 26 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical OPGN trend table...

Date Alert Name Type % Chg
Mar 18 Wide Bands Range Expansion 0.00%
Mar 18 Oversold Stochastic Weakness 0.00%
Mar 15 Wide Bands Range Expansion 0.83%
Mar 15 Oversold Stochastic Weakness 0.83%
Mar 14 NR7 Range Contraction 1.68%
Mar 14 Stochastic Reached Oversold Weakness 1.68%
Mar 14 Earnings Movers Other 1.68%
Mar 14 Oversold Stochastic Weakness 1.68%
Mar 13 Lower Bollinger Band Walk Weakness -0.82%
Mar 13 Earnings Movers Other -0.82%

Older signals for OPGN ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Health Healthcare Providers Pharmaceuticals Policy Antibiotic Bacteria Antimicrobial Resistance Veterinary Medicine Bioinformatics Evolutionary Biology Multi Drug Resistant Bacterial Infections
Is OPGN a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 2.9
52 Week Low 0.76
Average Volume 110,092
200-Day Moving Average 1.6491
50-Day Moving Average 1.4607
20-Day Moving Average 1.3479
10-Day Moving Average 1.2478
Average True Range 0.0917
ADX 22.85
+DI 14.198
-DI 23.1397
Chandelier Exit (Long, 3 ATRs ) 1.3149
Chandelier Exit (Short, 3 ATRs ) 1.4451
Upper Bollinger Band 1.5687
Lower Bollinger Band 1.1271
Percent B (%b) 0.19
BandWidth 32.762074
MACD Line -0.0647
MACD Signal Line -0.0489
MACD Histogram -0.0158
Fundamentals Value
Market Cap 62.38 Million
Num Shares 51.6 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -1.58
Price-to-Sales 5.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.33
Resistance 3 (R3) 1.34 1.30 1.31
Resistance 2 (R2) 1.30 1.27 1.30 1.30
Resistance 1 (R1) 1.26 1.25 1.24 1.25 1.30
Pivot Point 1.22 1.22 1.21 1.22 1.22
Support 1 (S1) 1.18 1.19 1.16 1.17 1.12
Support 2 (S2) 1.14 1.17 1.14 1.12
Support 3 (S3) 1.10 1.14 1.11
Support 4 (S4) 1.09